Acyl-4-carboxyphenylurea derivatives, processes for...

Details Acyl-4-carboxyphenylurea derivatives, processes for... Acyl-4-carboxyphenylurea derivatives, processes for...

2007-05-29

2007-05-29

Wilson, James O. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S563000, C548S236000, C548S577000, C544S106000, C562S439000

Reexamination Certificate

active

10410601

ABSTRACT:
The invention relates to acyl-4-carboxyphenylurea derivatives and to their physiologically tolerated salts and physiologically functional derivatives.The invention particularly relates to compounds of formula I,in which the radicals have the given meanings described herein, and to their physiologically tolerated salts and processes for preparing them. The compounds are, for example, suitable for use as antidiabetics.

REFERENCES:
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 2004/0077716 (2004-04-01), Defossa et al.
patent: 2004/0087659 (2004-05-01), Defossa et al.
patent: 101 42 734 (2003-03-01), None
patent: 0 136 745 (1984-08-01), None
patent: 0 193 249 (1986-03-01), None
patent: 0 193 249 (1986-09-01), None
patent: 0 298 314 (1989-01-01), None
patent: 0 462 884 (1991-12-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 02/081463 (2002-10-01), None
patent: WO 02/096864 (2002-12-01), None
A. Asakawa et al., “Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice”, Horm Metab Res, 2001, pp. 554-558, vol. 33.
P. Drueckes et al., “Photometric Microtiter Assay of Inorganic Phosphate in the Prescence of Acid-Labile Organic Phosphates”, Analytical Biochemistry, 1995, pp. 173-177, vol. 230.
H.D. Engers et al., “Kinetic Mechanism of Phosphorlyase a. I. Initial Velocity Studies”, Department of Biochemistry, University of Alberta, Edmonston 7, Alberta, Jan. 12, 1970, pp. 746-754.
Daniel W. Lee et al., “Leptin Agonists as a Potential Approach to the Treatment of Obesity”, Drugs of the Future, 2001, pp. 873-881, vol. 26, No. 9.
Hiroshi Okada et al., “Synthesis and Antitumor Activities of Prodrugs of Benzoylphenylureas”, Chem. Pharm. Bull, 1994, pp. 57-61, vol. 42, No. 1.
Javier Salvador et al., “Perspectives in the Therapeutic Use of Leptin”, Expert Opin. Pharmacother. 2001, pp. 1615-1622, vol. 2, No. 10.
Praveen Tyle, “Iontophoretic Devices for Drug Delivery”, Pharmaceutical Research, 1986, pp. 318-326, vol. 3, No. 6.
H.J.F. Zunft, “Carob Pulp Preparation for Treatment of Hypercholesterolemia”, Advances in Therapy, Sep./Oct. 2001, pp. 230-236, vol. 18, No. 5.

Affiliated with

Also associated with

Rating

Acyl-4-carboxyphenylurea derivatives, processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acyl-4-carboxyphenylurea derivatives, processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl-4-carboxyphenylurea derivatives, processes for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3730593